Researchers from the University of South Australia have found a way to make cannabidiol (CBD) work better in the body, potentially transforming how...

Researchers from the University of South Australia have found a way to make cannabidiol (CBD) work better in the body, potentially transforming how...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or...

REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel...

Early screening for lung diseases plays an important role in timely treatment and improving the quality of life for patients.

Alumis Inc, a clinical─stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple...

Bioxytran, Inc, a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, announced the signing of a...

A small pilot study has shown that deep brain stimulation (DBS), a surgical treatment that delivers electrical signals to specific areas of the brain,...